Winslow Garrett bought DMRA
July 3, 2026 · Form 4 insider transaction
Winslow Garrett bought 680 shares of Damora Therapeutics, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
680
Price
N/A
Total value
N/A
InsiderWinslow Garrett
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 3, 2026
Filing dateJuly 7, 2026
Shares owned after2,534
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents the right to receive, at settlement, one share of common stock of the Issuer. This transaction represents the settlement of RSUs in shares of common stock on their scheduled vesting date.